Contrave is contraindicated in people with seizure disorders, eating disorders (bulimia or anorexia), uncontrolled hypertension, or chronic opioid use
Clinical studies, such as the STEP trials, have shown that adults using semaglutide GLP-1 at the recommended dose (2.4 mg weekly) can lose an average of about 15% of their initial body weight over 68 weeks when combined with healthy lifestyle changes
The two medications work through completely separate mechanisms
The amount of weight you can expect to lose with Ozempic ( semaglutide ) as a GLP-1 medication varies from person to person, depending on factors like diet, exercise, and individual health conditions
These are all major concerns, and should be discussed with your doctor before starting any GLP-1, Sifonte said
These symptoms, while typically mild to moderate, can be severe enough to affect daily life